GSE230865 EYA2 knockdown 1 v 4 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE230865_EYA2 knockdown_1_v_4_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE230865_EYA2 knockdown_1_v_4_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE230865_EYA2 knockdown_1_v_4_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE230865_EYA2 knockdown_1_v_4_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

FGD5 antisense RNA 1

Gene

HLA complex group 18

Gene

prostate cancer associated transcript 7

Gene

SDHA pseudogene 1

Gene

polycystin 1, transient receptor potential channel interacting pseudogene 3

Gene

long intergenic non-protein coding RNA 221

Gene

acetylserotonin O-methyltransferase

Gene

septin 7 pseudogene 11

Gene

HPN antisense RNA 1

Gene

GSE1 antisense RNA 1

  • Gene

    FGD5 antisense RNA 1


  • Gene

    HLA complex group 18


  • Gene

    prostate cancer associated transcript 7


  • Gene

    SDHA pseudogene 1


  • Gene

    polycystin 1, transient receptor potential channel interacting pseudogene 3


  • Gene

    long intergenic non-protein coding RNA 221


  • Gene

    acetylserotonin O-methyltransferase


  • Gene

    septin 7 pseudogene 11


  • Gene

    HPN antisense RNA 1


  • Gene

    GSE1 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.